Register for More Information

Register Now

Find a Treatment Center

Enter your state or zip code to find a THERAKOSTM Photopheresis treatment center near you

Talk to your doctor to determine if treatment is right for you

 
 
 

Side Effects

Side Effects

Are there any side effects of which I should be aware?

 

The medication used in the photopheresis treatment will make you more sensitive to sunlight for about 24 hours after the treatment.

For this reason, you must take some simple, very important precautions to protect your eyes and skin. (Without taking these precautions, you put yourself at risk for cataracts or serious sunburns.)

THERAKOS™ Photopheresis is not intended for patients with a history of light-sensitive disease, an allergy to psoralen compounds, or who lack a lens in either eye.

For 24 hours, you should

  • Avoid sunlight as much as possible—even indirect sunlight coming through a window
  • Wear sunscreen (no lower than SPF 15) when exposed to sunlight (outdoors or indoors)
  • Wear UVA-protective, full-coverage sunglasses when exposed to sunlight

Other possible side effects usually go away within a day. These could include

  • Fatigue
  • Temporary increase in itchiness
  • Fever or redness appearing 6 to 8 hours after treatment.

The side effects that were clearly related to THERAKOS™ Photopheresis treatments and that resolved in 1 day are

  • Fever
  • Worsening of skin redness
  • Blood pressure changes during treatment

There is a small risk for developing an infection around the needle puncture site.

Talk to your doctor about any concerns you may have about potential risks or side effects.

 

 

Important Safety Information

Indications

Methoxsalen Sterile Solution is indicated for extracorporeal administration with the THERAKOS UVAR XTS® or THERAKOS CELLEX® Photopheresis System in the palliative treatment of the skin manifestations of cutaneous T-cell lymphoma (CTCL) that is unresponsive to other forms of treatment.

Methoxsalen is not appropriate for patients who have had a reaction to psoralen compounds, patients who have had a light sensitive disease, or patients with an absence of one or both lenses of the eye.

THERAKOS Photopheresis is not appropriate for patients who cannot tolerate blood volume changes or patients with blood clotting disorders. See Important Safety Information for additional details.

 
 

All contents Copyright © Therakos, Inc. 2001-2014.

This site is published by Therakos, Inc. which is solely responsible for its contents.

It is intended for visitors from the United States of America.